Enlivex Therapeutics Ltd
NASDAQ:ENLV

Watchlist Manager
Enlivex Therapeutics Ltd Logo
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Watchlist
Price: 0.755 USD 7.4% Market Closed
Market Cap: 18.3m USD

Wall Street
Price Targets

ENLV Price Targets Summary
Enlivex Therapeutics Ltd

Wall Street analysts forecast ENLV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ENLV is 7.14 USD with a low forecast of 7.07 USD and a high forecast of 7.35 USD.

Lowest
Price Target
7.07 USD
836% Upside
Average
Price Target
7.14 USD
846% Upside
Highest
Price Target
7.35 USD
874% Upside
Enlivex Therapeutics Ltd Competitors:
Price Targets
SCLP
Scancell Holdings PLC
219% Upside
MSB
Mesoblast Ltd
28% Upside
2142
Hbm Holdings Ltd
13% Upside
ACAD
ACADIA Pharmaceuticals Inc
14% Upside
2157
Lepu Biopharma Co Ltd
113% Upside
MDGL
Madrigal Pharmaceuticals Inc
3% Upside
AVCT
Avacta Group PLC
42% Upside
GOSS
Gossamer Bio Inc
234% Upside

Revenue
Forecast

Revenue Estimate
Enlivex Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Enlivex Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
Enlivex Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ENLV's stock price target?
Price Target
7.14 USD

According to Wall Street analysts, the average 1-year price target for ENLV is 7.14 USD with a low forecast of 7.07 USD and a high forecast of 7.35 USD.

Back to Top